Physician profile
Douglas Murphy
NPI 1225053408
$2,958.72
in general payments reported to CMS, 2019-2025
11 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $1,973 · 2021: $269 · 2022: $137 · 2023: $57.61 · 2024: $165 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,874.90 | 2020-2022 | |
| Stryker Corporation | $357.42 | 2019-2025 | Cobra, Slingshot, Alphavent |
| Zimmer Biomet Holdings, INC. | $305.42 | 2019-2024 | Affixus, A.L.P.S. |
| Pacira Therapeutics, INC. | $161.81 | 2019-2020 | |
| Smith+Nephew, INC. | $117.35 | 2021-2024 | Evos |
| Depuy Synthes Sales INC. | $30.19 | 2025 | Monovisc |
| Amgen INC. | $26.02 | 2025 | Krystexxa |
| Bioventus LLC | $25.85 | 2022 | |
| Medical Device Business Services, INC. | $21.18 | 2019 | |
| Ermi LLC | $20.86 | 2020 | |
| Medtronic USA, INC. | $17.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.